Jinka Rajeswari, Kapoor Renu, Sistla Pavana Goury, Raj T Avinash, Pande Gopal
Department of Biochemistry, Acharya Nagarjuna University, Guntur 522510, India.
Int J Cell Biol. 2012;2012:219196. doi: 10.1155/2012/219196. Epub 2012 Jan 4.
Cancer progression is a multistep process during which normal cells exhibit molecular changes that culminate into the highly malignant and metastatic phenotype, observed in cancerous tissues. The initiation of cell transformation is generally associated with genetic alterations in normal cells that lead to the loss of intercellular- and/or extracellular-matrix- (ECM-) mediated cell adhesion. Transformed cells undergo rapid multiplication and generate more modifications in adhesion and motility-related molecules which allow them to escape from the original site and acquire invasive characteristics. Integrins, which are multifunctional adhesion receptors, and are present, on normal as well as transformed cells, assist the cells undergoing tumor progression in creating the appropriate environment for their survival, growth, and invasion. In this paper, we have briefly discussed the role of ECM proteins and integrins during cancer progression and described some unique conditions where adhesion-related changes could induce genetic mutations in anchorage-independent tumor model systems.
癌症进展是一个多步骤过程,在此过程中,正常细胞会出现分子变化,最终形成在癌组织中观察到的高度恶性和转移性表型。细胞转化的起始通常与正常细胞中的基因改变有关,这些改变导致细胞间和/或细胞外基质(ECM)介导的细胞粘附丧失。转化细胞迅速增殖,并在与粘附和运动相关的分子中产生更多修饰,这使它们能够逃离原始部位并获得侵袭性特征。整合素是多功能粘附受体,存在于正常细胞和转化细胞上,有助于经历肿瘤进展的细胞创造适合其生存、生长和侵袭的环境。在本文中,我们简要讨论了ECM蛋白和整合素在癌症进展中的作用,并描述了一些独特的情况,即在非锚定依赖性肿瘤模型系统中,与粘附相关的变化可能会诱导基因突变。